Benign Prostatic Hyperplasia
Also written as BPH.
Benign Prostatic Hyperplasia (BPH) is an androgen-dependent proliferation of prostatic tissue in the transitional zone, causing obstructive and irritative urinary symptoms in many older men.
Benign Prostatic Hyperplasia (BPH / Nodular Hyperplasia)
- Extremely common — present in significant numbers by age 40; prevalence reaches 90% by the eighth decade.
- Does not occur in males castrated before puberty or in those with androgen insensitivity.
- Androgen-dependent proliferation of both stromal and glandular elements.
- DHT (dihydrotestosterone) is the key mediator, synthesized from testosterone by 5α-reductase type 2 in the prostate.
- DHT is 10x more potent than testosterone in binding androgen receptors.
Read this in Male Reproductive System Pathology
Benign Prostatic Hyperplasia (BPH)
- % of men by 8th decade; located in inner/transitional zone
- Gland typically weighs 60-100g; well-circumscribed nodules
- DHT (from testosterone via 5-alpha-reductase type 2) binds nuclear androgen receptors → promotes growth
- DHT is 10x more potent than testosterone
- Does not occur in castrated males or those with androgen insensitivity
Read this in Quick Guide: Male Reproductive System Pathology, Testis, Penis
What our notes say
- Benign Prostatic Hyperplasia (BPH) is an androgen-dependent proliferation of prostatic tissue in the transitional zone, causing obstructive and irritative urinary symptoms in many older men. (Male Reproductive System Pathology)
- Benign prostatic hyperplasia — a classic presentation of lower urinary tract symptoms in an elderly male. (Pathology Practical Revision Guide)
- Discuss benign prostatic hyperplasia and prostate carcinoma — pathogenesis, morphology, and clinical distinction. (Exam Prep: Skin Infections, Psoriasis & Pemphigus)
- Males: most common cause = benign prostatic hyperplasia (BPH) (Bladder Cancer & Urothelial Neoplasms: Types, Risks, Pathogenesis)
- Benign Prostatic Hyperplasia (BPH / Nodular Hyperplasia) (Male Reproductive System Pathology)
- It details conditions such as hypospadias, squamous cell carcinoma of the penis, cryptorchidism, testicular torsion, germ cell tumors, prostatitis, benign prostatic hyperplasia (BPH), and prostate carcinoma. (Penile & Testicular Pathologies: Hypospadias, Tumors, Torsion – Male Reproductiv)
Study material on Benign Prostatic Hyperplasia
- Male Reproductive System Pathology
- Penile & Testicular Pathologies: Hypospadias, Tumors, Torsion – Male Reproductiv
- Exam Prep: Skin Infections, Psoriasis & Pemphigus
- Female & Male Genital Pathology: Ulcers, HPV, Endometriosis, Pre-eclampsia
- CLINICAL BIOCHEMISTRY LAQs & SAQs
- Weekly Pathology Exam - September 11, 2026 (Sections B & C)
- Weekly Year 1: Anatomy Exam - May 22, 2026 (Section A: MCQs)
Practice questions on Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) typically originates in which zone of the prostate gland?
- Anterior zone
- Central zone
- Peripheral zone
- Transition zone
Answer: D. Benign prostatic hyperplasia (BPH) predominantly develops in the transition zone of the prostate, which surrounds the urethra. Prostate cancer typically originates in the peripheral zone.